← Research library

Modification of piracetam’s nootropic action by phenibut, Bemitil and Sydnocarb

Comparison in people · 2004

What was studied
Several animal and human experiments; human study settings separated in the program table
Main finding
Piracetam combinations were tested with Bemitil, phenibut or sydnocarb. In animals, the author describes a narrow range of supra-additivity, additive or antagonistic effects at other ratios, and faster Bemitil elimination with piracetam.

Piracetam + Bemitil · experimental interaction · Supra-additivity reported with Bemitil at 16–30% of total formulation mass · The dissertation reports additive effects outside that window and possible partial antagonism with further dose escalation. Animal hypoxia findings.

Related evidence maps: Military & occupational ↗

Reported findings and study design

122-page dissertation supervised by E. B. Shustov, with separate animal models, human experiments and pharmacokinetic observations.

Population or model Several animal and human experiments; human study settings separated in the program table

Results · Original dissertation conclusions in catalog transcription; primary tables not retrieved
MeasureResultComparison, timing and statistics
Piracetam + Bemitil · experimental interactionSupra-additivity reported with Bemitil at 16–30% of total formulation massThe dissertation reports additive effects outside that window and possible partial antagonism with further dose escalation. Animal hypoxia findings.
Bemitil eliminationApproximately twice as fast when co-administered with piracetamAuthor-reported pharmacokinetic conclusion; underlying estimates, sampling and model require the original tables.
Animal swim experimentPiracetam 90 mg/kg: +25%; Bemitil 37.5 mg/kg: +45%Author conclusions; separate tested doses, not a clinical comparison.
Other formulationsPirafen: piracetam + phenibut; Pirasid: piracetam + sydnocarbDistinct preparations and task-dependent results. The excerpt does not establish a universal benefit.
Human performance evidenceGroup-level estimates and complete allocation not recoveredSeparate studies within the dissertation; no basis for a clinical regimen.

An interaction can change direction with dose and endpoint. The animal and pharmacokinetic observations do not validate a human combination.

Source for these results ↗ · Reviewed 2026-11-08

Study limitations and source details

Study limitations

  • Experiments within one dissertation are not independent program replication.
  • OCR gaps, small groups and incomplete allocation details limit appraisal.
  • Combination exposure changes do not establish clinical synergy.

Related publications may describe some of the same participants or experiments.

Source details

Dissertation transcription · Author’s-abstract transcription

Dissertation excerpt and conclusions checked against the earlier source record; exact original interaction and pharmacokinetic tables not recovered.

Selected methods, ratio-dependent findings and pharmacokinetic conclusions

Sources checked

Citation

Human comparative studyRussian-language source

A. E. Kim. Modification of piracetam’s nootropic action by phenibut, Bemitil and Sydnocarb Candidate dissertation author’s abstract, Saint Petersburg, 2004

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards